In the first two cases, it was suggested that the peptide could serve as an effective adjuvant for a clinical drug to either prevent or treat acute respiratory distress syndrome (ARDS) that was frequent during the COVID-19 pandemic
Some doctors point to potential cancer risks as BPC-157 works in part by activating the focal adhesion kinase (FAK)paxillin pathway in cells that regulates how cells attach and move and helps with tissue repair
A 2025 systematic review published in Orthopaedic Journal of Sports Medicine , covering 36 studies from 1993 to 2024, found that BPC-157 promotes healing by boosting growth factors and reducing inflammation, with improved outcomes across muscle, tendon, ligament, and bone injury models in animals.4 The peptide enhances growth hormone receptor expression in tendon fibroblasts a key mechanism for tissue repair and regeneration.5 In the only published human orthopaedic data, seven of twelve patients with chronic knee pain reported relief lasting more than six months after a single BPC-157 injection.4 That is a small sample
Some insurance companies only pay 15% over the Medicaid rate in their state, whereas others pay 45%, 60%, 80%, 85% on top of their states medicaid rate
No evidence supports cycling versus continuous use, and no studies have determined optimal treatment duration
Muir CA, Clifton-Bligh RJ, Long GV, Scolyer RA, Lo SN, Carlino MS, Tsang VHM, Menzies AM
